Morgan R. Brown - 07 Dec 2021 Form 4 Insider Report for Lipocine Inc. (LPCN)

Reporting relationship: Chief Financial Officer
Issuer ticker: LPCN
Reported as of: 07 Dec 2021
Net transaction value: +$197,120
SEC form: 4
Accepted by SEC: 08 Dec 2021, 15:00:23 UTC
Next SEC filing: 03 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Morgan R. Brown

Key filing fact

Morgan R. Brown filed Form 4 for Lipocine Inc. (LPCN) on 08 Dec 2021.

Key facts

This page summarizes Morgan R. Brown's Form 4 filing for Lipocine Inc. (LPCN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Dec 2021, 15:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$197,120.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LPCN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $197,120
Shares: +176,000
Change %
Price: $1.12
Shares after: 176,000
Date: 07 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 176,000
Exercise price: $1.12
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.